Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.27 EUR | +3.01% | +7.65% | -51.74% |
May. 14 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
May. 06 | EVOTEC : Warburg Research reiterates its Buy rating | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.74% | 1.91B | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- EVT Stock
- News Evotec SE
- Evotec, Eli Lilly to Address Kidney Diseases, Diabetes in Three-Year Drug Discovery Collaboration